Propel Bio Partners announced the appointment of healthcare technology veteran Laurie Heilmann as Venture Partner, bringing more than three decades of commercialization and operational expertise to support the firm's investment strategy and portfolio companies from early development through successful exits. Heilman…
SHINE announced that it has completed its acquisition of Lantheus' SPECT business, including the North Billerica, Massachusetts SPECT manufacturing facility and its portfolio of diagnostic radiopharmaceuticals. The acquisition brings immediate revenue and operational scale in the $19 billion nuclear medicine market. S…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global l…
Advancium Health Network and its nonprofit subsidiary CobiCure announced the appointment of Michele Cleary, PhD, to Chief Executive Officer. Dr. Cleary, previously Advancium's President and Chief Scientific Officer, brings more than two decades of leadership in scientific innovation, drug development, and patient advo…
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, announced the appointment of Rick Fair as Chief Executive Officer and member of the Board of Directors of Enliven, effective December 11, 2025. Sam Kintz, Co-Founder and forme…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the appointment of Sanjeev Mehra to its Board of Directors, effective immediately. Mr. Mehra is Co-Founder and serves as Managing Partner of Periphas Cap…
Metagenics, announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of relevant leadership experience to Metagenics. Current President and CEO Pat Smallcombe, who has led Metagenics through a period of tremendous growth …
Tyra Biosciences, Inc., a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced the appointment of two key members of its leadership team: Bhavesh Ashar as Chief Operating Officer and…
Cipla Limited announced that it has elevated Achin Gupta, Global Chief Operating Officer, Cipla Limited to MD & GCEO effective April 1, 2026, for a term of 5 years. The appointment will be proposed to the shareholders for their approval. Achin has been appointed as MD & GCEO Designate from January 1st, 2026. A…
AMR Clinical, a leading integrated research site organization, announced today that Dr. William B. Smith, founding CEO of the Company since its formal consolidation in 2017, will assume a new role as Founder and Vice Chairman of the Board of Directors effective December 1, 2025. Kari L. Delahunty, currently Chief Oper…
Page 9 of 16